{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:02:10Z","timestamp":1791810130036,"version":"4.3.4"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijsu.2015.08.077","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T21:22:20Z","timestamp":1441747340000},"page":"273-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"PB","title":["Current status of hepatocyte xenotransplantation"],"prefix":"10.1097","volume":"23","author":[{"given":"Raphael P.H.","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalu","family":"Navarro-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-7741","authenticated-orcid":false,"given":"Henk-Jan","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo H.","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2015.08.077_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1067\/mlc.2001.119148","article-title":"Liver cell transplantation: the road to clinical application","volume":"138","author":"Allen","year":"2001","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.ijsu.2015.08.077_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-013-9656-5","article-title":"Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects","volume":"37","author":"Vogel","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ijsu.2015.08.077_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10545-006-0288-x","article-title":"Liver transplantation for inborn errors of liver metabolism","volume":"29","author":"Sokal","year":"2006","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ijsu.2015.08.077_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-1007096","article-title":"Hepatocyte transplantation for the treatment of human disease","volume":"19","author":"Strom","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ijsu.2015.08.077_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-199702270-00014","article-title":"Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure","volume":"63","author":"Strom","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2210-1-11","article-title":"Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs","volume":"1","author":"Soucek","year":"2001","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/xen.12007","article-title":"Comparison of hematologic, biochemical, and coagulation parameters in alpha1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species","volume":"19","author":"Ekser","year":"2012","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib8","first-page":"197","article-title":"Comparison of bile chemistry between humans, baboons, and pigs: implications for clinical and experimental liver xenotransplantation","volume":"48","author":"Kobayashi","year":"1998","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ijsu.2015.08.077_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00007890-199609270-00018","article-title":"Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination","volume":"62","author":"Cattan","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/xen.12170","article-title":"Experimental hepatocyte xenotransplantation-a comprehensive review of the literature","volume":"22","author":"Zhou","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib11","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.4049\/jimmunol.174.11.7302","article-title":"Intrinsic resistance of hepatocytes to complement-mediated injury","volume":"174","author":"Koch","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1432-2277.2008.00736.x","article-title":"In\u00a0vitro investigation of pig cells for resistance to human antibody-mediated rejection","volume":"21","author":"Hara","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ijsu.2015.08.077_bib13","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.92.11.4942","article-title":"Complete reconstitution of mouse liver with xenogeneic hepatocytes","volume":"92","author":"Rhim","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijsu.2015.08.077_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/hep.510280527","article-title":"Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats","volume":"28","author":"Arkadopoulos","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3727\/000000002783985729","article-title":"Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats","volume":"11","author":"Ahmad","year":"2002","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/104303401750061230","article-title":"Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex\u00a0vivo gene therapy","volume":"12","author":"Andreoletti","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijsu.2015.08.077_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00007890-200109150-00012","article-title":"Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases","volume":"72","author":"Vons","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.gastro.2006.10.013","article-title":"Prolonged survival of porcine hepatocytes in cynomolgus monkeys","volume":"132","author":"Nagata","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/TP.0b013e3181963ad3","article-title":"What clinical alternatives to whole liver transplantation? current status of artificial devices and hepatocyte transplantation","volume":"87","author":"Sgroi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e31823b72d6","article-title":"Current status of hepatocyte transplantation","volume":"93","author":"Hughes","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/xen.12111","article-title":"Increased transfusion-free survival following auxiliary pig liver xenotransplantation","volume":"21","author":"Yeh","year":"2014","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib22","doi-asserted-by":"crossref","first-page":"e29720","DOI":"10.1371\/journal.pone.0029720","article-title":"Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs","volume":"7","author":"Ekser","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijsu.2015.08.077_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12152","article-title":"Xenotransplantation: immunological hurdles and progress toward tolerance","volume":"258","author":"Griesemer","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijsu.2015.08.077_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/xen.12095","article-title":"islet cell xenotransplantation: a serious look towards the clinic","volume":"21","author":"Samy","year":"2014","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2004.11.041","article-title":"Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems","volume":"42","author":"Van de Kerkhove","year":"2005","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/gast.2003.50065","article-title":"Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation","volume":"124","author":"Nagata","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3727\/096368910X508915","article-title":"Treatment of acute liver failure in mice by hepatocyte xenotransplantation","volume":"19","author":"Yamamoto","year":"2010","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-3089.2005.00248.x","article-title":"Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes","volume":"12","author":"Mai","year":"2005","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3727\/096368909788237168","article-title":"Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice","volume":"18","author":"Mei","year":"2009","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cmi.2010.83","article-title":"CD47: a new player in phagocytosis and xenograft rejection","volume":"8","author":"Navarro-Alvarez","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3727\/096368913X663604","article-title":"Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation","volume":"23","author":"Navarro-Alvarez","year":"2014","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib32","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/hep.25816","article-title":"Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice","volume":"56","author":"Waern","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/500840","article-title":"Liver-stage development of Plasmodium falciparum, in a humanized mouse model","volume":"193","author":"Morosan","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijsu.2015.08.077_bib34","doi-asserted-by":"crossref","first-page":"e0119820","DOI":"10.1371\/journal.pone.0119820","article-title":"A\u00a0novel mouse model for stable engraftment of a human immune system and human hepatocytes,","volume":"10","author":"Strick-Marchand","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ijsu.2015.08.077_bib35","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.4049\/jimmunol.172.10.6460","article-title":"Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity","volume":"172","author":"Baumann","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib36","first-page":"934","article-title":"Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice","volume":"23","author":"Kawahara","year":"2010","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ijsu.2015.08.077_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/xen.12110","article-title":"Species-specific regulation of fibrinogen synthesis with implications for porcine hepatocyte xenotransplantation","volume":"21","author":"Ramackers","year":"2014","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-3089.2008.00478.x","article-title":"Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression","volume":"15","author":"Kleine","year":"2008","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/lt.20918","article-title":"Physiological incompatibilities of porcine hepatocytes for clinical liver support","volume":"12","author":"Schrem","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/hep.26307","article-title":"Role of procoagulant microparticles in mediating complications and outcome of acute liver injury\/acute liver failure","volume":"58","author":"Stravitz","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/btpr.226","article-title":"Progress technology in microencapsulation methods for cell therapy","volume":"25","author":"Rabanel","year":"2009","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ijsu.2015.08.077_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2013.12.073","article-title":"Cell encapsulation via microtechnologies","volume":"35","author":"Kang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijsu.2015.08.077_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-62703-550-7_23","article-title":"Therapeutic applications of encapsulated cells","volume":"1051","author":"Acarregui","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib44","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/ma902469f","article-title":"Alginate-poly(ethylene glycol) hybrid microspheres with adjustable physical properties","volume":"43","author":"Mahou","year":"2010","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijsu.2015.08.077_bib45","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.actbio.2011.03.011","article-title":"Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model","volume":"7","author":"Rokstad","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijsu.2015.08.077_bib46","doi-asserted-by":"crossref","first-page":"e91268","DOI":"10.1371\/journal.pone.0091268","article-title":"Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow","volume":"9","author":"Meier","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijsu.2015.08.077_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/ma7010275","article-title":"Alginate-poly(ethylene glycol) hybrid microspheres for primary cell microencapsulation","volume":"7","author":"Mahou","year":"2014","journal-title":"Materials"},{"key":"10.1016\/j.ijsu.2015.08.077_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00572552","article-title":"Barium-cross-linked alginate beads - a simple, one-step method for successful immunoisolated transplantation of islets of Langerhans","volume":"29","author":"Zekorn","year":"1992","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbm.a.31472","article-title":"Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique","volume":"83","author":"Thanos","year":"2007","journal-title":"J.\u00a0Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijsu.2015.08.077_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0883911510372173","article-title":"Development of a novel cell encapsulation system based on natural origin polymers for tissue engineering applications","volume":"25","author":"Luna","year":"2010","journal-title":"J.\u00a0Bioact. Compat. Polym."},{"key":"10.1016\/j.ijsu.2015.08.077_bib51","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1021\/bm801330j","article-title":"Core-cross-linked alginate microcapsules for cell encapsulation","volume":"10","author":"Mazumder","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijsu.2015.08.077_bib52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0142-9612(92)90180-V","article-title":"Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes","volume":"13","author":"Sawhney","year":"1992","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijsu.2015.08.077_bib53","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1016\/j.biomaterials.2010.08.004","article-title":"Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation","volume":"31","author":"Luan","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijsu.2015.08.077_bib54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1399-3089.2010.00606.x","article-title":"Creation of a prevascularized site for cell transplantation in rats","volume":"17","author":"Stiegler","year":"2010","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib55","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.actbio.2011.04.001","article-title":"Physical and structural characteristics of acrylated poly(ethylene glycol)-alginate conjugates","volume":"7","author":"Davidovich-Pinhas","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijsu.2015.08.077_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11095-009-0017-x","article-title":"Bioactive long-term release from\u00a0biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in\u00a0vivo response to purified alginate","volume":"27","author":"Giovagnoli","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijsu.2015.08.077_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biomaterials.2007.09.006","article-title":"Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using \u201cbead-in-bead\u201d polysaccharide capsules","volume":"29","author":"Babister","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijsu.2015.08.077_bib58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jbm.a.32270","article-title":"Biocompatibility and in\u00a0vivo evaluation of oligochitosans as cationic modifiers of alginate\/Ca microcapsules","volume":"15","author":"De Castro","year":"2009","journal-title":"J.\u00a0Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijsu.2015.08.077_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/masy.201200099","article-title":"Combined electrostatic and covalent polymer networks for cell microencapsulation","volume":"329","author":"Mahou","year":"2013","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.ijsu.2015.08.077_bib60","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2014.10.030","article-title":"Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice","volume":"62","author":"Meier","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ijsu.2015.08.077_bib61","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1073\/pnas.1402216111","article-title":"Device design and materials optimization of conformal coating for islets of Langerhans","volume":"111","author":"Tomei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijsu.2015.08.077_bib62","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-199706270-00003","article-title":"Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats","volume":"63","author":"Gomez","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ijsu.2015.08.077_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-199807000-00001","article-title":"Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study","volume":"228","author":"Roger","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijsu.2015.08.077_bib64","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3727\/096368911X564976","article-title":"Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration","volume":"20","author":"Sgroi","year":"2011","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ijsu.2015.08.077_bib65","doi-asserted-by":"crossref","first-page":"e113609","DOI":"10.1371\/journal.pone.0113609","article-title":"Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure","volume":"9","author":"Jitraruch","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijsu.2015.08.077_bib66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ijsu.2015.08.077_bib67","unstructured":"Safety and efficacy of ELAD to treat acute liver failure (ALF), https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01875874?term=ELAD&rank=4. (accessed 12.07.15)."},{"key":"10.1016\/j.ijsu.2015.08.077_bib68","unstructured":"Study to assess safety and efficacy of ELAD in subjects with severe acute alcoholic hepatitis (sAAH) and Lille score failure, https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01829347?term=ELAD&rank=5. (accessed 12.07.15)."},{"key":"10.1016\/j.ijsu.2015.08.077_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1399-3089.2009.00541.x","article-title":"The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes\u2013chapter 2: source pigs,","volume":"16","author":"Schuurman","year":"2009","journal-title":"Xenotransplantation"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919115011899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919115011899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:01:26Z","timestamp":1677063686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919115011899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":69,"alternative-id":["S1743919115011899"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.077","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of hepatocyte xenotransplantation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}